Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Zhejiang University. Medical sciences ; (6): 687-696, 2020.
Artigo em Chinês | WPRIM | ID: wpr-879930

RESUMO

OBJECTIVE@#To investigate the mechanism of Chinese medicine Buyang Huanwu decoction (BYHWD) promoting neurogenesis and angiogenesis in ischemic stroke rats.@*METHODS@#Male SD rats were randomly divided into sham operation group, model group, BYHWD group, antagonist group and antagonist control group with 14 rats in each. Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery for 90 min with intraluminal filament and reperfusion for 14 d in all groups except sham operation group. BYHWD (13 g/kg) was administrated by gastrogavage in BYHWD group, antagonist group and antagonist control group at 24 h after modeling respectively, and BrdU (50 mg/kg) was injected intraperitoneally in all groups once a day for 14 consecutive days. miR-199a-5p antagomir or NC (10 nmol) was injected into the lateral ventricle at d5 after ischemia in antagonist and antagonist control groups, respectively. The neurological deficits were evaluated by the modified neurological severity score (mNSS) and the corner test, and the infract volume was measured by toluidine blue staining. Neurogenesis and angiogenesis were detected by immunofluorescence double labeling method. The expression level of miR-199a-5p was tested by real-time RT-PCR, and the protein expressions of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) were determined by Western blotting.@*RESULTS@#BYHWD treatment significantly promoted the recovery of neurological function (@*CONCLUSIONS@#Buyang Huanwu decoction promotes neurogenesis and angiogenesis in rats with cerebral ischemia, which may be related to increased protein expression of VEGF and BDNF through upregulating miR-199a-5p.


Assuntos
Animais , Masculino , Ratos , Isquemia Encefálica/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , AVC Isquêmico/tratamento farmacológico , MicroRNAs/genética , Neurogênese/efeitos dos fármacos , Ratos Sprague-Dawley , Regulação para Cima/efeitos dos fármacos , Fator A de Crescimento do Endotélio Vascular/genética
2.
Journal of Zhejiang University. Science. B ; (12): 253-263, 2019.
Artigo em Inglês | WPRIM | ID: wpr-1010455

RESUMO

Valproic acid (VPA), an agent that is used to treat epileptic seizures, can cause spatial memory impairment in adults and children. This effect is thought to be due to the ability of VPA to inhibit neurogenesis in the hippocampus, which is required for learning. We have previously used an animal model to show that VPA significantly impairs hippocampal-spatial working memory and inhibits neuronal generation in the sub-granular zone of the dentate gyrus. As there are patient reports of improvements in memory after discontinuing VPA treatment, the present study investigated the recovery of both spatial memory and hippocampal neurogenesis at two time points after withdrawal of VPA. Male Wistar rats were given intraperitoneal injections of 0.9% normal saline or VPA (300 mg/kg) twice a day for 10 d. At 1, 30, or 45 d after the drug treatment, the novel object location (NOL) test was used to examine spatial memory; hippocampal cell division was counted using Ki67 immunohistochemistry, and levels of brain-derived neurotrophic factor (BDNF) and Notch1 were measured using western immunoblotting. Spatial working memory was impaired 1 and 30 d after the final administration, but was restored to control levels by 45 d. Cell proliferation had increased to control levels at 30 and 45 d. Both markers of neurogenesis (BDNF and Notch1 levels) had returned to control levels at 45 d. These results demonstrate that memory recovery occurs over a period of six weeks after discontinuing VPA treatment and is preceded by a return of hippocampal neurogenesis to control levels.


Assuntos
Animais , Masculino , Ratos , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Proliferação de Células , Cognição/efeitos dos fármacos , Giro Denteado/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Hipocampo/metabolismo , Imuno-Histoquímica , Transtornos da Memória/terapia , Memória de Curto Prazo/efeitos dos fármacos , Neurogênese/efeitos dos fármacos , Neurônios/metabolismo , Ratos Wistar , Receptor Notch1/metabolismo , Memória Espacial/efeitos dos fármacos , Ácido Valproico/farmacologia
3.
Journal of Veterinary Science ; : 13-20, 2016.
Artigo em Inglês | WPRIM | ID: wpr-110770

RESUMO

In this study, we investigated the effects of chronic aluminum (Al) exposure for 10 weeks on cell proliferation and neuroblast differentiation in the hippocampus of type 2 diabetic rats. Six-week-old Zucker diabetic fatty (ZDF) and Zucker lean control (ZLC) rats were selected and randomly divided into Al- and non-Al-groups. Al was administered via drinking water for 10 weeks, after which the animals were sacrificed at 16 weeks of age. ZDF rats in both Al- and non-Al-groups showed increases in body weight and blood glucose levels compared to ZLC rats. Al exposure did not significantly affect body weight, blood glucose levels or pancreatic β-cells and morphology of the pancreas in either ZLC or ZDF rats. However, exposure to Al reduced cell proliferation and neuroblast differentiation in both ZLC and ZDF rats. Exposure to Al resulted in poor development of the dendritic processes of neuroblasts in both ZLC and ZDF rats. Furthermore, onset and continuation of diabetes reduced cell proliferation and neuroblast differentiation, and Al exposure amplified reduction of these parameters. These results suggest that Al exposure via drinking water aggravates the impairment in hippocampal neurogenesis that is typically observed in type 2 diabetic animals.


Assuntos
Animais , Alumínio/toxicidade , Glicemia/análise , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus Tipo 2/patologia , Modelos Animais de Doenças , Hipocampo/efeitos dos fármacos , Neurogênese/efeitos dos fármacos , Distribuição Aleatória , Ratos Zucker
4.
Journal of Veterinary Science ; : 245-251, 2015.
Artigo em Inglês | WPRIM | ID: wpr-66462

RESUMO

Inducible cyclooxygenase-2 (COX-2) has received much attention because of its role in neuro-inflammation and synaptic plasticity. Even though COX-2 levels are high in healthy animals, the function of this factor in adult neurogenesis has not been clearly demonstrated. Therefore, we performed the present study to compare the effects of pharmacological and genetic inhibition of COX-2 on adult hippocampal neurogenesis. Physiological saline or the same volume containing celecoxib was administered perorally every day for 5 weeks using a feeding needle. Compared to the control, pharmacological and genetic inhibition of COX-2 reduced the appearance of nestin-immunoreactive neural stem cells, Ki67-positive nuclei, and doublecortin-immunoreactive neuroblasts in the dentate gyrus. In addition, a decrease in phosphorylated cAMP response element binding protein (pCREB) at Ser133 was observed. Compared to pharmacological inhibition, genetic inhibition of COX-2 resulted in significant reduction of neural stem cells, cell proliferation, and neuroblast differentiation as well as pCREB levels. These results suggest that COX-2 is part of the molecular machinery that regulates neural stem cells, cell proliferation, and neuroblast differentiation during adult hippocampal neurogenesis via pCREB. Additionally, genetic inhibition of COX-2 strongly reduced neural stem cell populations, cell proliferation, and neuroblast differentiation in the dentate gyrus compared to pharmacological inhibition.


Assuntos
Animais , Masculino , Camundongos , Celecoxib/farmacologia , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Ciclo-Oxigenase 2/genética , Inibidores de Ciclo-Oxigenase 2/farmacologia , Giro Denteado/efeitos dos fármacos , Camundongos Knockout , Células-Tronco Neurais/efeitos dos fármacos , Neurogênese/efeitos dos fármacos
5.
Journal of Veterinary Science ; : 27-33, 2014.
Artigo em Inglês | WPRIM | ID: wpr-69673

RESUMO

In this study, we determined how rosiglitazone (RSG) differentially affected hippocampal neurogenesis in mice fed a low-fat diet (LFD) or high-fat diet (HFD; 60% fat). LFD and HFD were given to the mice for 8 weeks. Four weeks after initiating the LFD and HFD feeding, vehicle or RSG was administered orally once a day to both groups of mice. We measured cell proliferation and neuroblast differentiation in the subgranular zone of the dentate gyrus using Ki67 and doublecortin (DCX), respectively, as markers. In addition, we monitored the effects of RSG on the levels of DCX and brain-derived neurotrophic factor (BDNF) in hippocampal homogenates. At 8 weeks after the LFD feeding, the numbers of Ki67- and DCX-positive cells as well as hippocampal levels of DCX and BDNF were significantly decreased in the RSG-treated group compared to the vehicle-treated animals. In contrast, the numbers of Ki67- and DCX-positive cells along with hippocampal levels of DCX and BDNF in the HFD fed mice were significantly increased in the RSG-treated mice compared to the vehicle-treated group. Our data demonstrate that RSG can modulate the levels of BDNF, which could play a pivotal role in cell proliferation and neuroblast differentiation in the hippocampal dentate gyrus.


Assuntos
Animais , Masculino , Western Blotting , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Giro Denteado/crescimento & desenvolvimento , Dieta com Restrição de Gorduras , Dieta Hiperlipídica , Hipocampo/crescimento & desenvolvimento , Hipoglicemiantes/farmacologia , Imuno-Histoquímica , Antígeno Ki-67/metabolismo , Camundongos Endogâmicos C57BL , Proteínas Associadas aos Microtúbulos/metabolismo , Neurogênese/efeitos dos fármacos , Neuropeptídeos/metabolismo , Tiazolidinedionas/farmacologia
6.
Journal of Gorgan University of Medical Sciences. 2011; 13 (2): 9-15
em Persa | IMEMR | ID: emr-117382

RESUMO

Memory is an especial ability of brain in which saves the information and reuptake it. The memory is depended on hippocampus and amigdal. The neuronal density of hippocampus and amigdal have direct effect on their physiological functions. Cannabis sativa is belongs to Cannabinaceae family that Tetrahidrocanabinol is important component of this plant. The aim of this study was to assess the effect of alcoholic extract of Cannabis sativa on CA1, CA2 and CA3 subfields of hippocampus neuronal density in male Rats. This experimental study was performed on 18 male Rats with [250- 320gr] weight and 3 months old in faculty of science, Islamic Azad University of Mashhad, Iran [2010-2011]. At first the alcoholic extraction was provided by the soxhlet method of the seed of this plant with coded 2548. Eighteen male wistar Rats were allocated into 2 experimental groups [25,75mg/kg of alcoholic extract of Cannabis sativa] and one control group. Alcoholic extract of Cannabis sativa was injected intraperitonealy [I.P.] in experimental groups for two weeks [every week one injection]. After four weeks animal was decapitated and their brain dissected, fixed in 10% formalin, sectioned in 7?m thickness and stained by toluidin blue. By applying stereological techniques and systematic random sampling scheme the neuronal density of hippocampus were estimated. Neuronal density in control and treated with alcoholic extract [25,75mg/kg] CA1 was 17982, 26750 and 22801 respectively. Neuronal density in CA2 was 19171, 26750 and 22801 respectively and also in CA3 was 19391, 24043, 28571 respectively. Neuronal density in CA1, CA2 and CA3 of hippocampus in treated groups with alcoholic extract [25,75mg/kg] was significantly increased in comparison with controls [P<0.01]. This study determined that the alcoholic extract of Cannabis sativa can induce hippocampus neurogenesis which is not dose depended


Assuntos
Animais de Laboratório , Masculino , Hipocampo/efeitos dos fármacos , Neurogênese/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Modelos Animais , Ratos , Receptores de Canabinoides
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA